Ryerson Holding (RYI) CEO discloses RSU dividend equivalent rights

Rhea-AI Filing Summary

Ryerson Holding Corp President & CEO, who is also a director, reported the acquisition of additional restricted stock unit-based awards linked to prior grants. On December 18, 2025, dividend equivalent rights were credited in the form of restricted stock units covering 94.477, 184.8, and 267.534 shares of Ryerson common stock, each at a price of $0 per unit. These units arise as dividends are paid on the underlying common shares and follow the same vesting and settlement terms as the original restricted stock units granted in 2023, 2024, and 2025. The unvested restricted stock units and related dividend equivalents are scheduled to vest on March 31, 2026, and in some cases also on March 31, 2027 and March 31, 2028, reflecting ongoing equity-based compensation for the executive.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lehner Edward J.

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/18/2025		A		94.477(2)		(3)	(3)	Common Stock	94.477	$0	13,134.738	D
Restricted Stock Units	(1)	12/18/2025		A		184.8(2)		(4)	(4)	Common Stock	184.8	$0	25,691.99	D
Restricted Stock Units	(1)	12/18/2025		A		267.534(2)		(5)	(5)	Common Stock	267.534	$0	37,194.244	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").

2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.

3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026.

4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027.

5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028.

	/s/ Camilla Rykke Merrick, attorney-in-fact	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Ryerson Holding Corp (RYI) report?

The President & CEO, who is also a director, reported the acquisition of restricted stock units in the form of dividend equivalent rights on December 18, 2025, tied to existing restricted stock unit awards.

How many restricted stock units were credited to the Ryerson (RYI) executive?

Dividend equivalent rights were credited as restricted stock units covering 94.477, 184.8, and 267.534 shares of Ryerson common stock, each recorded at a price of $0 per unit.

What are dividend equivalent rights in the Ryerson (RYI) Form 4?

Dividend equivalent rights are amounts that accrue on underlying restricted stock units when dividends are paid on Ryerson common shares and are settled as additional restricted stock units that vest and expire on the same terms as the related awards.

When will the Ryerson (RYI) restricted stock units and dividend equivalents vest?

The filing states that unvested restricted stock units and related dividend equivalent rights from grants made in 2023, 2024, and 2025 are scheduled to vest on March 31, 2026, and for later grants also on March 31, 2027 and March 31, 2028.

Does the Ryerson (RYI) executive pay cash for these restricted stock units?

The reported dividend equivalent restricted stock units were recorded at a price of $0 per unit, reflecting that they are credited as part of existing equity compensation rather than purchased for cash.

Which prior awards generated these Ryerson (RYI) dividend equivalent rights?

The dividend equivalent rights accrued on restricted stock units that were originally granted on March 31, 2023, March 31, 2024, and March 31, 2025, and that remained outstanding as of December 18, 2025.